Expanding HIV Therapy: Will Devices Pick Up Where Drugs Leave Off?
This article was originally published in The Gray Sheet
Executive Summary
The realization that combination drug therapy for HIV can lose its clout over time has prompted device makers to focus efforts on projects that may represent new hope to patients otherwise out of options
You may also be interested in...
Aethlon Aims To Lure Drug Makers To Device Biz With Disease-Filtering Technology
Aethlon Medical is looking to repurpose the disease-filtering technology behind its investigational Hemopurifier device to attract drug company partnerships.
Aethlon Aims To Lure Drug Makers To Device Biz With Disease-Filtering Technology
CEO Jim Joyce says firm is in early discussions with several drug companies about prospects to partner on product development with the newly introduced Aethlon ADAPT filtration platform technology.
Aethlon Aims To Lure Drug Makers To Device Biz With Disease-Filtering Technology
Aethlon Medical is looking to repurpose the disease-filtering technology behind its investigational Hemopurifier device to attract drug company partnerships.